Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-31 15:00 |
Change in number of shares and votes in Alligator Bioscience
|
English | 53.3 KB | ||
| 2025-01-31 15:00 |
Ändring av antalet aktier och röster i Alligator Bioscience
|
Swedish | 54.0 KB | ||
| 2025-01-29 08:30 |
The subscription period in Alligator Bioscience’s rights issue begins today
|
English | 81.6 KB | ||
| 2025-01-29 08:30 |
Idag börjar teckningsperioden för Alligator Biosciences företrädesemission
|
Swedish | 81.1 KB | ||
| 2025-01-24 14:15 |
Alligator Bioscience publishes prospectus in connection with forthcoming rights…
|
English | 84.4 KB | ||
| 2025-01-24 14:15 |
Alligator Bioscience offentliggör prospekt i samband med företrädesemission
|
Swedish | 83.3 KB | ||
| 2025-01-22 08:00 | Swedish | 2.6 MB | |||
| 2025-01-22 08:00 | English | 2.6 MB | |||
| 2025-01-17 18:30 |
Alligator Bioscience announces final terms of rights issue
|
English | 96.9 KB | ||
| 2025-01-17 18:30 |
Alligator Bioscience offentliggör slutliga villkor i företrädesemission
|
Swedish | 97.2 KB | ||
| 2025-01-13 12:00 |
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
|
English | 65.6 KB | ||
| 2025-01-13 12:00 |
Kommuniké från extra bolagsstämma i Alligator Bioscience AB
|
Swedish | 65.9 KB | ||
| 2025-01-13 12:00 |
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
|
English | 65.6 KB | ||
| 2025-01-13 12:00 |
Kommuniké från extra bolagsstämma i Alligator Bioscience AB
|
Swedish | 65.9 KB | ||
| 2024-12-30 15:00 |
Ändring av antalet aktier och röster i Alligator Bioscience
|
Swedish | 58.2 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
